交银医药创新股票C(014046)资产配置 |
|
报告日期 |
股票(元) |
债券(元) |
基金总资产(元) |
基金净值(元) |
股票占净值比 |
2024/3/31 |
2,854,020,000 |
2,493,420 |
3,294,690,000 |
3,274,330,000 |
87% |
2023/12/31 |
3,432,290,000 |
- |
3,908,430,000 |
3,875,490,000 |
89% |
2023/9/30 |
3,185,110,000 |
2,131 |
3,636,210,000 |
3,625,580,000 |
88% |
2023/6/30 |
3,206,040,000 |
2,218 |
3,760,790,000 |
3,729,840,000 |
86% |
2023/3/31 |
3,588,260,000 |
- |
4,181,740,000 |
4,167,550,000 |
86% |
2022/12/31 |
3,231,420,000 |
- |
3,717,510,000 |
3,690,270,000 |
88% |
2022/9/30 |
2,705,150,000 |
- |
3,387,350,000 |
3,369,450,000 |
80% |
2022/6/30 |
3,512,490,000 |
1,274 |
4,259,640,000 |
4,204,050,000 |
84% |
2022/3/31 |
2,642,370,000 |
693 |
3,173,200,000 |
3,159,790,000 |
84% |
2021/12/31 |
3,453,080,000 |
314,400 |
3,932,800,000 |
3,915,920,000 |
88% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。